King & Spalding advises TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia

King & Spalding advised TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia.

TVM Capital Healthcare, a Dubai-based specialist investment management firm, operates within the healthcare sector and its investment strategy is built around becoming a strategic partner of companies in the sector by injecting equity capital and acting as a highly active shareholder. The investment into Boston Oncology Arabia helps to increase TVM Capital Healthcare’s footprint within Saudi Arabia.

Boston Oncology Arabia is a leading manufacturer and distributor of biogeneric drugs operating in Saudi Arabia.

A team of lawyers from Riyadh, Dubai, Atlanta, and London offices advised TVM Capital Healthcare on the transaction. The team included Martin Hunt, Nabil A. Issa, Sunandini Das, Saud Aldawsari, Mohammed Basama, Jamie Kershaw, Husni Al Far, Michael Nunnally and Catherine Munro.